Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NEWR | Common Stock | Options Exercise | $508K | +30K | $16.93* | 30K | Jan 3, 2022 | Direct | ||
transaction | NEWR | Common Stock | Sale | -$1.02M | -9.68K | -32.28% | $105.71 | 20.3K | Jan 3, 2022 | Direct | F1, F2 |
transaction | NEWR | Common Stock | Sale | -$1.55M | -14.5K | -71.45% | $106.56 | 5.8K | Jan 3, 2022 | Direct | F1, F3 |
transaction | NEWR | Common Stock | Sale | -$558K | -5.2K | -89.66% | $107.40 | 600 | Jan 3, 2022 | Direct | F1, F4 |
transaction | NEWR | Common Stock | Sale | -$32.6K | -300 | -50% | $108.59 | 300 | Jan 3, 2022 | Direct | F1, F5 |
transaction | NEWR | Common Stock | Sale | -$33K | -300 | -100% | $110.04 | 0 | Jan 3, 2022 | Direct | F1, F6 |
transaction | NEWR | Common Stock | Sale | -$676K | -6.4K | -0.12% | $105.71 | 5.48M | Jan 3, 2022 | By Trust | F1, F2, F7 |
transaction | NEWR | Common Stock | Sale | -$1.04M | -9.8K | -0.18% | $106.58 | 5.47M | Jan 3, 2022 | By Trust | F1, F7, F8 |
transaction | NEWR | Common Stock | Sale | -$365K | -3.4K | -0.06% | $107.38 | 5.47M | Jan 3, 2022 | By Trust | F1, F7, F9 |
transaction | NEWR | Common Stock | Sale | -$21.7K | -200 | 0% | $108.55 | 5.47M | Jan 3, 2022 | By Trust | F1, F7, F10 |
transaction | NEWR | Common Stock | Sale | -$22K | -200 | 0% | $110.06 | 5.47M | Jan 3, 2022 | By Trust | F1, F6, F7 |
holding | NEWR | Common Stock | 274K | Jan 3, 2022 | By Trust | F11 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NEWR | Stock Option (Right to Buy) | Options Exercise | $0 | -30K | -7.79% | $0.00 | 355K | Jan 3, 2022 | Common Stock | 30K | $16.93 | Direct | F12 |
Id | Content |
---|---|
F1 | Shares sold pursuant to a 10b5-1 plan. |
F2 | The shares were sold at prices ranging from $105.10 to $106.095. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F3 | The shares were sold at prices ranging from $106.10 to $107.07. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F4 | The shares were sold at prices ranging from $107.12 to $108.06. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F5 | The shares were sold at prices ranging from $108.24 to $109.01. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F6 | The shares were sold at prices ranging from $110.01 to $110.11. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F7 | Shares are held directly by Lewis Cirne and Kirsten L. Vliet, as Trustees of the Cirne Family Revocable Trust UAD March 20, 2012. |
F8 | The shares were sold at prices ranging from $106.12 to $107.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F9 | The shares were sold at prices ranging from $107.13 to $107.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F10 | The shares were sold at prices ranging from $108.25 to $108.84. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
F11 | The shares are held directly by J.P. Morgan Trust Company of Delaware, as Trustee of the Cirne Family 2012 Irrevocable Trust. |
F12 | Fully vested and exercisable. |